GlassScriptPhysician profile
Eileen M Farley
NPI 1326665381
$3,953.79
in general payments reported to CMS, 2019-2025
9 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,084 · 2024: $254 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,023 · Food and Beverage: $1,734 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,022.63 |
| Food and Beverage | $1,734.33 |
| Education | $196.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,542.59 | 2023-2025 | |
| Acumed LLC | $1,528.94 | 2023 | Osteomed, Accuplate Patient-Specific Plate, Acumed |
| Organogenesis INC. | $387.49 | 2023 | Puraply |
| Davol INC. | $148.66 | 2023 | Arista Ah Flexitip |
| Paratek Pharmaceuticals, INC. | $134.66 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $116.06 | 2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $42.17 | 2023 | |
| Smith+Nephew, INC. | $26.80 | 2023 | Regranex |
| Integra Lifesciences Corporation | $26.42 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.